Budesonide’s antiviral effect against SARS-CoV-2
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease 19 (COVID-19), emerged in December 2019
Read more
The potential therapeutic value of CDK6 inhibitors in critical COVID-19
While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of
Read more
RNA-binding cylinders inhibit SARS-CoV-2 replication in vitro
Research led by Michael J. Hannon from the University of Birmingham, UK, finds metallo-supramolecular helicates (cylinders) binding to untranslated regions
Read more